Biopharma leaders met in Spain to discuss the ways how AI-optimised supply chains can safeguard clinical trials against global trade instability. Credit: gorodenkoff / Getty Images. The role of AI in supply chain management proved to be the focal issue […]
Amid deglobalising trade, experts seek AI safeguards for clinical trial supply Read More »
Machine learning tools can account for innumerable factors outside of regular capabilities, adjusting biopharma material orders for cost, efficiency, emissions, and desired stock. Credit: stocklapse / Getty Images. Widespread integration of machine learning (ML) into supply chain management by major
Machine learning adoption into supply chain management on the horizon Read More »
From the Covid-19 pandemic to Trump’s tariffs, external forces are tempting Europe to seek independent biopharma production, but experts warn the benefits of global trade could render this unfeasible. Credit: ugurhan / Getty Images. In step with international news in
Are European biopharma manufacturers ‘nearshoring’? Read More »
An empowered MSSG will allow the EU to address medicine shortages by enforcing drug sharing between member states. Credit: Frankie Fattorini/ GlobalData Earlier this month, the newly empowered role of the European Union (EU)’s Executive Steering Group on Shortages and
Mandatory drug stock monitoring empowers EU to tackle shortages Read More »
Clinical trial sponsors can expect a “one set of documents paradigm” says Andreas Schwinn, , senior qualified person (QP) for investigational medicinal products (IMPs) at Roche. This should allow faster approvals and counteract drug shortages. Credit: Frankie Fattorini/ GlobalData A
New EU trial regulations could expedite approvals and address shortages Read More »
Clinical trial sponsors can expect a “one set of documents paradigm” says Andreas Schwinn, with faster approvals and fewer generic drug shortages. Credit: Frankie Fattorini/ GlobalData A major overhaul and consolidation of EU clinical trial regulations is paving the way
New EU trial regulations could expedite approvals and lessen shortages Read More »
Marcel Walraven, key account director, Biocair, speaking at the Clinical Trial Supply Europe Conference in Barcelona. The difficulties involved in biopharmaceutical transport, rather than stifling international supply, could bolster business for courier middlemen. Credit: Frankie Fattorini/ GlobalData Despite concerns of
Supply chain uncertainties present opportunities for biopharma couriers in 2025 Read More »
Eisbach Bio is developing EIS-12656, which works by inhibiting ALC1 (chromodomain-helicase-DNA-binding protein 1-like), a chromatin remodeller and DNA helicase also involved in DNA repair. Image credit: Shutterstock/PeopleImages.com – Yuri A Eisbach Bio plans to use a $4.75m grant to advance
Eisbach Bio positions HRD-targeting therapy to supplant PARP inhibitors Read More »
Locking horns with activist investor Starboard Value, Pfizer CEO Albert Bourla’s position seems increasingly secure. Credit: Ryan Muir/ Getty Images Amidst dwindling share prices and widespread criticism, Pfizer CEO Albert Bourla appears to have withstood an attempted ousting by activist
How Pfizer management outplayed activist investor Starboard Read More »
The study published in Nature shows the drastic economic cost of obesity through medical expenses and lost productivity. Credit: zimmytws/Getty Images A new study published in Nature Nutrition & Diabetes estimates the economic burden associated with obesity on major US
New study finds obesity costs US industry $347bn a year Read More »
